Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

312 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Immunogenicity and safety of a multicomponent meningococcal serogroup B vaccine and a quadrivalent meningococcal CRM197 conjugate vaccine against serogroups A, C, W-135, and Y in adults who are at increased risk for occupational exposure to meningococcal isolates.
Kimura A, Toneatto D, Kleinschmidt A, Wang H, Dull P. Kimura A, et al. Among authors: kleinschmidt a. Clin Vaccine Immunol. 2011 Mar;18(3):483-6. doi: 10.1128/CVI.00304-10. Epub 2010 Dec 22. Clin Vaccine Immunol. 2011. PMID: 21177912 Free PMC article.
A phase III observer-blind randomized, controlled study to evaluate the immune response and the correlation with nasopharyngeal carriage after immunization of university students with a quadrivalent meningococcal ACWY glycoconjugate or serogroup B meningococcal vaccine.
Read RC, Dull P, Bai X, Nolan K, Findlow J, Bazaz R, Kleinschmidt A, McCarthy M, Wang H, Toneatto D, Borrow R. Read RC, et al. Among authors: kleinschmidt a. Vaccine. 2017 Jan 11;35(3):427-434. doi: 10.1016/j.vaccine.2016.11.071. Epub 2016 Nov 29. Vaccine. 2017. PMID: 27912986 Free article. Clinical Trial.
Treatment with the interleukin-17A-blocking antibody secukinumab does not interfere with the efficacy of influenza and meningococcal vaccinations in healthy subjects: results of an open-label, parallel-group, randomized single-center study.
Chioato A, Noseda E, Stevens M, Gaitatzis N, Kleinschmidt A, Picaud H. Chioato A, et al. Among authors: kleinschmidt a. Clin Vaccine Immunol. 2012 Oct;19(10):1597-602. doi: 10.1128/CVI.00386-12. Epub 2012 Aug 8. Clin Vaccine Immunol. 2012. PMID: 22875601 Free PMC article. Clinical Trial.
Influenza and meningococcal vaccinations are effective in healthy subjects treated with the interleukin-1 beta-blocking antibody canakinumab: results of an open-label, parallel group, randomized, single-center study.
Chioato A, Noseda E, Felix SD, Stevens M, Del Giudice G, Fitoussi S, Kleinschmidt A. Chioato A, et al. Among authors: kleinschmidt a. Clin Vaccine Immunol. 2010 Dec;17(12):1952-7. doi: 10.1128/CVI.00175-10. Epub 2010 Oct 20. Clin Vaccine Immunol. 2010. PMID: 20962212 Free PMC article. Clinical Trial.
Demonstration of active neutron interrogation of special nuclear materials using a high-intensity short-pulse-laser-driven neutron source.
Favalli A, Henzlova DC, Croft S, Deppert O, Falk K, Fernandez JC, Gautier DC, Guler N, Hamilton CE, Ianakiev KD, Iliev M, Johnson RP, Kleinschmidt A, Roth M, Shimada TN, Swinhoe M, Taddeucci TN. Favalli A, et al. Among authors: kleinschmidt a. Sci Rep. 2025 Jan 3;15(1):724. doi: 10.1038/s41598-024-82641-y. Sci Rep. 2025. PMID: 39753631 Free PMC article.
312 results